Given the pivotal role of TFE3 oncofusion condensates in driving pro-oncogenic transcription, we hypothesized that disrupting this process might suppress tRCC cell growth. The gene discussed is TFE3; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.